Pharmacovigilance & Regulatory News

February 2008
Reactions Weekly;2/9/2008, Issue 1188, p3
The article reports on the alert issued by New Zealand's Medsafe to healthcare professionals about an increased risk of suicidal thoughts and behaviours in antiepileptic drug recipients. Medsafe issued the alert after an analysis by the U.S. Food and Drug Administration (FDA) which revealed that risk of suicidal ideation or behavior is almost double in people receiving antiepileptics, and advise people taking antiepileptic drugs to consult their physicians before making changes to their drug regimen


Related Articles

  • Are antiepileptics really associated with suicidality?  // Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p6 

    The article discusses the highlights of studies on side effects of antiepileptic drugs (AEDs) presented at the 2009 meeting of the American Epilepsy Society (AES) in the U.S. A presentation during the meeting criticized an analysis which showed the risks of suicidal ideation and suicidal...

  • SUICIDE. TATUM IV, WILLIAM O.; KAPLAN, PETER W.; JALLON, PIERRE // Epilepsy A to Z: A Concise Encyclopedia;2009, p327 

    An encyclopedia entry for "suicide" is presented. It is noted that people with epilepsy (PWE) are ten times more likely to commit suicide than the general population. Risk factors associated with suicide include an axis 1 diagnosis, physical health problems, family issues and life stressors. The...

  • Antiepileptics: suicidal behaviour.  // Reactions Weekly;2/28/2009, Issue 1241, p4 

    The article reports on a study conducted by the Netherlands Pharmacovigilance Centre (Lareb) on reports of suicidal ideation, suicidal attempt or suicide in patients receiving antiepileptic drugs. The study was conducted to determine whether the findings by the U.S. Food and Drug Administration...

  • The Suicidal Process: Time to Intervene? Kuritzky, Louis // Internal Medicine Alert;3/15/2009 Clinical Briefs, p39 

    The article focuses on a study conducted by researcher E.A. Deisenhammer and colleagues, regarding the interval between first suicidal ideation and the ultimate carrying out of a suicide attempt.

  • Clinician Perspectives of the Therapeutic Use of the Self-confrontation Procedure with Suicidal Clients. Popadiuk, Natalee; Young, Richard A.; Valach, Ladislav // Journal of Mental Health Counseling;Jan2008, Vol. 30 Issue 1, p14 

    This research investigated clinician perspectives of the therapeutic use of the self-confrontation procedure with suicidal clients. The self-confrontation procedure, which involves the use of video playback of interviews with clients who have experienced suicidal ideation and attempts, has...

  • Antiepileptic drugs carry small increased risk of suicidal thoughts.  // Reactions Weekly;8/16/2008, Issue 1215, p2 

    The article reports that antiepileptic drugs may carry a slight increased risk of suicidal thoughts and behaviour, according to a European review published in "Drug Safety Update." The review also took into consideration data obtained from published literature, postmarketing surveillance and a...

  • Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. VanCott, Anne C.; Cramer, Joyce A.; Copeland, Laurel A.; Zeber, John E.; Steinman, Michael A.; Dersh, Jeffrey J.; Glickman, Mark E.; Mortensen, Eric M.; Amuan, Megan E.; Pugh, Mary Jo // BMC Medicine;2010, Vol. 8, Special section p1 

    Background: The U.S. Food and Drug Administration (FDA) recently linked antiepileptic drug (AED) exposure to suicide-related behaviors based on meta-analysis of randomized clinical trials. We examined the relationship between suicide-related behaviors and different AEDs in older veterans...

  • Risk of suicidal ideation almost double with antiepileptics.  // Reactions Weekly;2/9/2008, Issue 1188, p1 

    The article discusses research on the risk of suicidal ideation on people taking antiepileptic drugs. It references a study by the U.S. Food and Drug Administration (FDA) published in the January 31, 2008 issue of "Internet Document." The FDA examined 199 placebo-controlled clinical studies...

  • Suicidal risk warnings to be added to antiepileptics.  // Reactions Weekly;1/10/2009, Issue 1234, p2 

    The article reports on the announcement of the U. S. Food and Drug Administration (FDA) that it will require manufacturers of antiepileptic drugs to add a warning to the products' prescribing information or labelling that their use increases the risk of suicidal thoughts and behaviours. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics